Literature DB >> 10564130

PKC-dependent activation of p46/p54 JNKs during ischemic preconditioning in conscious rabbits.

P Ping1, J Zhang, S Huang, X Cao, X L Tang, R C Li, Y T Zheng, Y Qiu, A Clerk, P Sugden, J Han, R Bolli.   

Abstract

A conscious rabbit model was used to study the effect of ischemic preconditioning (PC) on stress-activated kinases [c-Jun NH(2)-terminal kinases (JNKs) and p38 mitogen-activated protein kinase (MAPK)] in an environment free of surgical trauma and attending external stress. Ischemic PC (6 cycles of 4-min ischemia/4-min reperfusion) induced significant activation of protein kinase C (PKC)-epsilon in the particulate fraction, which was associated with activation of p46 JNK in the nuclear fraction and p54 JNK in the cytosolic fraction; all of these changes were completely abolised by the PKC inhibitor chelerythrine. Selective enhancement of PKC-epsilon activity in adult rabbit cardiac myocytes resulted in enhanced activity of p46/p54 JNKs, providing direct in vitro evidence that PKC-epsilon is coupled to both kinases. Studies in rabbits showed that the activation of p46 JNK occurred during ischemia, whereas that of p54 JNK occurred after reperfusion. A single 4-min period of ischemia induced a robust activation of the p38 MAPK cascade, which, however, was attenuated after 5 min of reperfusion and disappeared after six cycles of 4-min ischemia/reperfusion. Overexpression of PKC-epsilon in cardiac myocytes failed to increase the p38 MAPK activity. These results demonstrate that ischemic PC activates p46 and p54 JNKs via a PKC-epsilon-dependent signaling pathway and that there are important differences between p46 and p54 JNKs with respect to the subcellular compartment (cytosolic vs. nuclear) and the mechanism (ischemia vs. reperfusion) of their activation after ischemic PC.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10564130     DOI: 10.1152/ajpheart.1999.277.5.H1771

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  20 in total

Review 1.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

Review 2.  Organ preconditioning: the past, current status, and related lung studies.

Authors:  Shi-ping Luh; Pan-chyr Yang
Journal:  J Zhejiang Univ Sci B       Date:  2006-05       Impact factor: 3.066

3.  SIRT1 modulates MAPK pathways in ischemic-reperfused cardiomyocytes.

Authors:  Matteo Becatti; Niccolò Taddei; Cristina Cecchi; Niccolò Nassi; Paolo Antonio Nassi; Claudia Fiorillo
Journal:  Cell Mol Life Sci       Date:  2012-02-05       Impact factor: 9.261

4.  Ischemic Neuroprotectant PKCε Restores Mitochondrial Glutamate Oxaloacetate Transaminase in the Neuronal NADH Shuttle after Ischemic Injury.

Authors:  Jing Xu; Nathalie Khoury; Charles W Jackson; Iris Escobar; Samuel D Stegelmann; Kunjan R Dave; Miguel A Perez-Pinzon
Journal:  Transl Stroke Res       Date:  2019-08-31       Impact factor: 6.829

5.  Insulin-like growth factor-1 preconditioning accentuates intrinsic survival mechanism in stem cells to resist ischemic injury by orchestrating protein kinase cα-erk1/2 activation.

Authors:  Gang Lu; Muhammad Ashraf; Khawaja Husnain Haider
Journal:  Antioxid Redox Signal       Date:  2011-10-26       Impact factor: 8.401

6.  Aldehydes potentiate alpha(2)(I) collagen gene activity by JNK in hepatic stellate cells.

Authors:  F A Anania; L Womack; M Jiang; N K Saxena
Journal:  Free Radic Biol Med       Date:  2001-04-15       Impact factor: 7.376

7.  Heat shock proteins and mitogen-activated protein kinases in steatotic livers undergoing ischemia-reperfusion: some answers.

Authors:  Marta Massip-Salcedo; Araní Casillas-Ramirez; Rosah Franco-Gou; Ramón Bartrons; Ismail Ben Mosbah; Anna Serafin; Joan Roselló-Catafau; Carmen Peralta
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

8.  Protein kinase Cε targets respiratory chain and mitochondrial membrane potential but not F0 F1 -ATPase in renal cells injured by oxidant.

Authors:  Grazyna Nowak; Diana Bakajsova-Takacsova
Journal:  J Cell Biochem       Date:  2018-08-03       Impact factor: 4.429

Review 9.  Mitogen-activated protein kinases: a new therapeutic target in cardiac pathology.

Authors:  Tána Ravingerová; Miroslav Barancík; Monika Strnisková
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

10.  Effect of p38 MAP kinases on contractility and ischemic injury in intact heart.

Authors:  H R Cross; M Li; B G Petrich; E Murphy; Y Wang; Charles Steenbergen
Journal:  Acta Physiol Hung       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.